Jump to content

List of pharmaceutical companies

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Edgar181 (talk | contribs) at 12:59, 4 November 2014 (Reverted edits by 183.82.101.138 (talk) to last version by Edgar181). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

The following is a list of the twelve largest pharmaceutical companies ranked here by revenue according to their released 2013 annual reports.

Rank Company Country Total Revenues (USD billions) Total Revenues (reported currency in millions of USD) Change 2012 (%) Net income/ (loss) (reported currency in millions) Change 2012 (%) R&D Expenses (reported currency in millions) Change 2012 (%) Fortune 500 Ranking[1] Accurate as of (Date) Sources
1 Johnson & Johnson[2] United States 71.3[3] 71,312 6.1 13831 27.4 2411 3.4 121 2014 (2013 Annual Report) 2013 Full-Year Report
2 Pfizer[4] United States 51.6 51584 6.0 22003 51.0 6678 13.0 191 2014 (2013 Annual Report) 2013 Full-Year Report
3 Roche[5] Switzerland 52.1[6] 52080 6.0 12652 22.0 9678 5.0 196 2014 (2013 Annual Report) 2013 Full-Year Report
4 GlaxoSmithKline[7] United Kingdom 45.4[8] 45402 1.0 8015 -0.5 3929 11.3 170 2014 (2013 Annual Report) 2013 Full-Year Report
5 Novartis[9] Switzerland 57.9[10] 57920 4.0 9292 7 9600 5.5 157 2014 (2013 Annual Report) 2013 Full-Year Report
6 Sanofi[11] France 44.6[12] 44563 6.5 9043 17.1 1685 -8.0 238 2014 (2013 Annual Report) 2013 Full-Year Report
7 AstraZeneca[13] UK/Sweden 25.7[14] 25711 -6.0 8390 -22 4269 0.7 468 2014 (2013 Annual Report) 2013 Full-Year Report
8 Abbott Laboratories[15] United States 21.8[16] 21848 4.0 2576 -56.8 1452 -6.0 136 2014 (2013 Annual Report) 2013 Full-Year Report
9 Merck & Co.[17] United States 44.0[18] 44000 -7.0 4404 -28.6 7503 -8.1 241 2014 (2013 Annual Report) 2013 Full-Year Report
10 Bayer HealthCare[19] Germany 54.2[20] 54211 1.0 4702 32.5 4306 5.9 ?154 2014 (2013 Annual Report) 2013 Full-Year Report
11 Eli Lilly[21] United States 23.1[22] 23113 2.0 4684 15 5531 5.0 129 2014 (2013 Annual Report) 2013 Full-Year Report
12 Bristol-Myers Squibb[23] United States 16.4[24] 16385 7.0 2340 23.5 3715 0.7 176 2014 (2013 Annual Report) 2013 Full-Year Report

The following is a list of the twelve largest healthcare companies ranked by revenue as of July 2009 in the Fortune Global 500.[25]

Rank[25] Company Country Total Revenues (USD millions) Net income/ (loss) (USD millions) Employees
1 Johnson & Johnson United States 63,747.0[26] 12,949.0 118,700
2 Pfizer United States 48,296.0[27] 8,104.0 81,800
3 GlaxoSmithKline United Kingdom 44,654.0[28] 8,438.6 99,003
4 Roche Switzerland 44,267.5[29] 8,288.1 80,080
5 Sanofi-Aventis France 42,179.0[30] 5,636.7 98,213
6 Novartis Switzerland 41,459.0[31] 8,195.0 96,717
7 AstraZeneca United Kingdom/Sweden 31,601.0[32] 6,101.0 65,000
8 Abbott Laboratories United States 29,527.6[33] 4,880.7 68,838
9 Merck United States 23,850.3[34] 7,808.4 55,200
10 Wyeth United States 22,833.9[35] 4,417.8 47,426
11 Bristol-Myers Squibb United States 21,366.0[36] 5,247.0 35,000
12 Eli Lilly United States 20,378.0[37] (2,071.9) 40,500

The following is a list of the 43 largest companies involved in pharmaceutical and biotech industry ranked by healthcare revenue as of 2008.[38] Some companies (e.g., Bayer) have additional revenue not included here.[39][40]

Rank[38] Company Country Total Revenues (USD millions) Healthcare R&D 2008 (USD millions) Net income/ (loss) 2008 (USD millions) Employees 2008
1 Pfizer[41] (with Wyeth[42]) United States 70,696 11,318 14,111 137,127
2 Johnson & Johnson United States 63,747 NA 10,576 119,200
3 Hoffmann–La Roche Switzerland 43,970 NA 8,135 78,604
4 Novartis Switzerland 41,460 NA 11,946 98,200
5 GlaxoSmithKline United Kingdom 40,424 6,373 10,432 103,483
6 Sanofi-Aventis France 40,328 NA 7,204 99,495
7 AstraZeneca United Kingdom/Sweden 31,601 NA 5,959 67,400
8 Abbott Laboratories[43] United States 29,527 2,688 4,880 68,697
9 Merck & Co. United States 23,850 4,678 7,808 74,372
10 Bristol-Myers Squibb United States 19,977 NA 2,165 42,000
11 Eli Lilly and Company United States 18,634 NA 2,953 40,600
12 Boehringer Ingelheim Germany 16,959 1,977 2,163 43,000
13 Takeda Pharmaceutical Co. Japan 15,697 1,620 2,870 15,000
14 Bayer [44] Germany 15,407 3,770 6,448 108,600
15 Amgen United States 14,771 3,366 3,166 48,000
16 Actavis Ireland N/A N/A N/A N/A
17 Baxter International United States 12,300 614 1,397 38,428
18 Teva Pharmaceutical Industries Israel 11,080 495 546 26,670
19 Astellas Pharma Japan 10,701 1,435 1,122 23,613
20 Daiichi Sankyo Japan 9,682 1,459 671 20,100
21 Novo Nordisk Denmark 9,081 1,063 1,922 26,575
22 Valeant Pharmaceuticals Canada NA NA NA NA
23 Eisai Japan 5,583 926 604 14,993
24 Merck KGaA Germany 5,175 772 1,258 13,900
26 SINOPHARM China 4,700 498 1249 9700
27 Akzo Nobel Netherlands 4,694 741 1,449 13,000
28 UCB Belgium 4,426 1,024 492 12,741
29 Nycomed Switzerland 4,264 NA -105 10,533
30 Solvay Belgium 3,268 533 1,026 9,000
31 Genzyme United States 3,187 650 -17 8,477
32 Allergan United States 3,063 1,056 -127 8,423
33 Gilead Sciences United States 3,026 384 -1,190 6,772
35 CSL Australia 2,788 161 454 6,400
35 Chugai Pharmaceutical Co. Japan 2,787 467 328 5,962
36 Biogen Idec United States 2,683 718 218 5,907
37 Taiho Pharmaceutical Japan 2,069 244 132 5,756
38 Mitsubishi Pharma Japan 1,945 403 208 5,111
39 Dainippon Sumitomo Pharma Japan 1,763 350 193 3,750
40 Kyowa Hakko Japan 1,698 268 108 2,895
41 Shionogi Japan 1,640 320 159 2,868
42 Mylan Laboratories United States 1,612 104 217 2,800
43 H. Lundbeck Denmark 1,552 329 186 2,515

Alphabetical listing

This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources.

It is limited to those companies notable enough to have articles in Wikipedia.

1-A

B-D

E-L

M

N

O

P

R

S-T

U-Z

Notes and references

  1. ^ "FORTUNE 500 2014".
  2. ^ "Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results". 2010. Retrieved 2 March 2010. {{cite journal}}: Cite journal requires |journal= (help)
  3. ^ "Johnson & Johnson 2013 Full-Year Report" (PDF). Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results:. Johnson & Johnson. 21 January 2014. Retrieved 16 July 2014.{{cite web}}: CS1 maint: extra punctuation (link)
  4. ^ "2009 Pfizer Financial Report". 2010. Retrieved 2 March 2010. {{cite journal}}: Cite journal requires |journal= (help)
  5. ^ "09 Roche in Brief" (PDF). 2010. Retrieved 2 March 2010. {{cite journal}}: Cite journal requires |journal= (help)
  6. ^ "Roche in Brief" (PDF).
  7. ^ "Annual Reports". 2010. Retrieved 2 March 2010. {{cite journal}}: Cite journal requires |journal= (help)
  8. ^ "Press Release 4th Quarter 2013 for GSK" (PDF).
  9. ^ "Annual Report 2009". 2010. Retrieved 2 March 2010. {{cite journal}}: Cite journal requires |journal= (help)
  10. ^ "Novartis Financial Results 2013" (PDF).
  11. ^ "Annual Results 2009". 2010. Retrieved 2 March 2010. {{cite journal}}: Cite journal requires |journal= (help)
  12. ^ "Sanofi Returns to Growth in Q4 2013" (PDF).
  13. ^ "Condensed Consolidated Statement of Comprehensive Income" (PDF). 2010. Retrieved 2 March 2010. {{cite journal}}: Cite journal requires |journal= (help)
  14. ^ "AstraZeneca Annual Report" (PDF).
  15. ^ "Annual Report 2009". 2010. Retrieved 29 April 2010. {{cite journal}}: Cite journal requires |journal= (help)
  16. ^ "2013 Annual Report Abbot".
  17. ^ "Merck Announces Fourth-Quarter and Full-Year 2009 Financial Results". Merck & Co. 20 July 2009. Retrieved 12 February 2010. {{cite journal}}: Cite journal requires |journal= (help)
  18. ^ "MERCK ANNUAL REPORT 2013" (PDF).
  19. ^ "Annual Report 009". 2010. Retrieved 2 March 2010. {{cite journal}}: Cite journal requires |journal= (help)
  20. ^ "Annual Report 2013 Bayer".
  21. ^ "Lilly Reports Fourth-Quarter and Full-Year 2009 Results". 2010. Retrieved 2 March 2010. {{cite journal}}: Cite journal requires |journal= (help)
  22. ^ "ELI LILLY AND COMPANY 2013 ANNUAL REPORT" (PDF).
  23. ^ "2009 Annual Report" (PDF). 2010. Retrieved 29 April 2010. {{cite journal}}: Cite journal requires |journal= (help)
  24. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results".
  25. ^ a b "Fortune Global 500 2009 Pharmaceutical Industry". Fortune. 160 (2). July 2009. Retrieved 18 December 2009.
  26. ^ "Johnson & Johnson - JNJ". Fortune. 20 July 2009. Retrieved 12 February 2010.
  27. ^ "Pfizer - PFE". Fortune. 20 July 2009. Retrieved 12 February 2010.
  28. ^ "GlaxoSmithKline - GSK". Fortune. 20 July 2009. Retrieved 12 February 2010.
  29. ^ "Roche Group - RHHVF". Fortune. 20 July 2009. Retrieved 12 February 2010.
  30. ^ "Sanofi-Aventis - SNY". Fortune. 20 July 2009. Retrieved 12 February 2010.
  31. ^ "Novartis - NVS". Fortune. 20 July 2009. Retrieved 12 February 2010.
  32. ^ "AstraZeneca - AZN". Fortune. 20 July 2009. Retrieved 12 February 2010.
  33. ^ "Abbott Laboratories - ABT". Fortune. 20 July 2009. Retrieved 12 February 2010.
  34. ^ "Merck - MRK". Fortune. 20 July 2009. Retrieved 12 February 2010.
  35. ^ "Wyeth - WYE". Fortune. 20 July 2009. Retrieved 12 February 2010.
  36. ^ "Bristol-Myers Squibb - BMY". Fortune. 20 July 2009. Retrieved 12 February 2010.
  37. ^ "Eli Lilly - LLY". Fortune. 20 July 2009. Retrieved 12 February 2010.
  38. ^ a b "Global 500". CNN. 2008. Retrieved 27 July 2009.
  39. ^ "Company Structure". 2009. Retrieved 3 March 2010. {{cite journal}}: Cite journal requires |journal= (help)
  40. ^ "Profile and Organization". 1 January 2010. Retrieved 3 March 2010. {{cite journal}}: Cite journal requires |journal= (help)
  41. ^ "Pfizer Annual Report" (PDF). 2008. Retrieved 24 July 2009.
  42. ^ "Wyeth Annual Report" (PDF). 2008. Retrieved 24 July 2009.
  43. ^ "Abbott Annual Report" (PDF). 2008. Retrieved 24 July 2009.
  44. ^ "Kennzahlen Bayer Konzern". 2008. Retrieved 27 July 2009.

See also


Retrieved from "https://en.wikipedia.org/w/index.php?title=List_of_pharmaceutical_companies&oldid=632413192"